CAJ | 학술논문

应积极控制妊娠期支气管哮喘(简称哮喘)确保母婴健康;对不同级别的持续性哮喘可应用不同剂量吸人性激素控制(推荐布地奈德),当病情不能得到很好控制时,可根据药物妊娠危险性的分类标准和2004年美国哮喘教育和预防项目(NAEPP)妊娠哮喘防治指南选择其他药物;哮喘控制药物妊娠期应用的安全性和有效性仍需进一步评价.
응적겁공제임신기지기관효천(간칭효천)학보모영건강;대불동급별적지속성효천가응용불동제량흡인성격소공제(추천포지내덕),당병정불능득도흔호공제시,가근거약물임신위험성적분류표준화2004년미국효천교육화예방항목(NAEPP)임신효천방치지남선택기타약물;효천공제약물임신기응용적안전성화유효성잉수진일보평개.
Bronchial asthma(asthma)should be controlled during pregnancy to ensure maternal and infant health.Different dosages of inhaled corticosteroid(preferably budesonide)are recommended for different levels of persistent asthma,and when illness can not be well controlled,other asthma controller medications should be selected according to the US Food and Drug Administration(FDA)pregnancy category ratings and the 2004 updated recommendations from the national asthma education and prevention program (NAEPP).The safety and effectiveness of many asthma controller medications during pregnancy are still uncertain and need further investigation.